Shares of Pfizer offer a yield above 7% at recent prices. Pfizer is a pharmaceutical giant that has raised its dividend every ...

Pfizer Pfizer (NYSE: PFE) is a dividend powerhouse, with a recent dividend yield of 7.1%. That payout has been growing, too, ...

A former Pfizer scientist was subpoenaed Monday by House Republicans over allegations that there was a conspiracy among ...

The Justice Department changed its policy on foreign corruption cases, which might have put an end to investigations into the ...

The House Judiciary Committee subpoenaed a former Pfizer executive who allegedly claimed senior members of the company ...

In spite of its sustainable moat, Palantir Technologies is butting heads with historical headwinds that have a flawless track ...

Union momentum grows in Ireland’s €100bn pharma sector as Trump’s tariff threats and weak labour laws fuel worker unrest ...

In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the ...

Pfizer offers a high 7.4% dividend yield and trades at low valuation multiples. Click here to read more about PFE stock and why it is a Buy.

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.

House Judiciary Chair Jim Jordan subpoenaed Dr. Philip Dormitzer after he refused to testify in the 2020 vaccine delay probe, ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...